This article is more than 5 years old. Information may no longer be current.
STAAR reports strong growth in Q2 refractive product sales
Click Here to Manage Email Alerts
MONROVIA, Calif. — STAAR Surgical Co. reported improved performance for the second quarter 2006, driven by refractive product sales, according to a press release.
Second quarter product sales totaled approximately $14.6 million, a 4.7% increase over the second quarter 2005 and a 9.4% increase over the first quarter 2006. For the first six months of 2006, product sales increased 1% over the same period last year to total approximately $27.9 million, according to the release.
The company achieved 106.9% year-over-year sales growth in its refractive business, totaling approximately $3.45 million. Company officials attributed the growth to increased sales of STAAR’s Visian ICL, which grew 76%. Visian ICL and refractive support product sales in the United States totaled approximately $1.3 million for the quarter, with U.S. sales of ICLs totaling approximately $1.2 million.
International ICL and toric ICL sales grew 26.3% over the second quarter 2005 to approximately $2.1 million. Year-to-date international sales of ICLs and toric ICLs grew 24.9% to approximately $3.8 million.
Cataract product sales in the U.S. declined 8.1% for the quarter compared with the same period of 2005, but grew 7.4% over the first quarter 2006, according to the release.